Nasal Polyps: Clinical Trials

157 trials for Nasal Polyps, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 28 unknown, 16 recruiting, 11 terminated. 39 Not applicable, 34 Phase 3, 27 Phase 2, 19 Phase 4, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable39Completed 15, Unknown 9, Recruiting 6, Not yet recruiting 5, Terminated 2, Active not recruiting 1, Enrolling by invitation 1
Phase 334Completed 23, Unknown 5, Recruiting 2, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 227Completed 21, Terminated 2, Unknown 2, Active not recruiting 1, Recruiting 1
Phase 419Completed 5, Recruiting 4, Unknown 4, Terminated 3, Active not recruiting 2, Withdrawn 1
Phase 17Unknown 3, Completed 2, Terminated 2
Early Phase 11Completed 1

Follow Nasal Polyps: new trials by email Literature Review of Nasal Polyps trials Research Report on Nasal Polyps

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
China CRSwNP Registry Study
Routine Clinical Care for CRSwNP - Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Not yet recruitingBeijing Tongren Hospital10002026-10-312026-08-31
FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps
Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray, Functional Endoscopic Sinus Surgery - Chronic Sinusitis, Nasal Polyposis
Not applicableNot yet recruitingServices Institute of Medical Sciences, Pakistan1742026-10-152026-10-23
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
GSK5784283, Placebo, Standard of Care - Nasal Polyps
Phase 3RecruitingGlaxoSmithKline2182026-09-282026-10-14
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
GSK5784283, Placebo, Standard of Care - Nasal Polyps
Phase 3RecruitingGlaxoSmithKline2182026-09-032026-10-09
Active vs. Passive VR During Office-based ENT Procedures
Passive virtual reality headset or goggles, Active virtual reality headset or goggles - Pain, Anxiety
Not applicableNot yet recruitingCedars-Sinai Medical Center1322026-09-012026-08-17
Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Polymorphonuclear Cells in the Middle Turbinate
Sinonasal sample collection and inflammatory assessment - Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Not applicableNot yet recruitingUniversity Hospital, Montpellier602026-08-012026-04-13
Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Depemokimab - Nasal Polyps
Phase 4RecruitingGlaxoSmithKline282026-07-152026-09-08
Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps
Budesonide - CRSwNP, Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis
Not applicableNot yet recruitingSt. Paul's Sinus Centre102026-07-012026-04-14
Biologics in Chronic Rhinosinusitis With Nasal Polyposis
Biologic Agents - Chronic Sinusitis, Nasal Polyps
Phase 4RecruitingMedical University of South Carolina5042026-06-032026-09-28
Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
Stapokibart, Matched placebo - Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Not applicableNot yet recruitingBeijing Tongren Hospital482026-06-012026-06-01
Triamcinolone Nanocapsules After Endoscopic Nasal Surgery
Triamcinolone Acetonide-Loaded Polymeric Nanocapsules, Normal Saline Nasal Irrigation - Chronic Rhinosinusitis (CRS), Nasal Polyps
Phase 2RecruitingDeraya University502026-05-012026-07-27
Metabolic and Immunologic Biomarkers in Chronic Rhinosinusitis With Nasal Polyps
Nasal polyp tissue and blood sampling, Nasal mucosa and blood sampling - Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Nasal Polyps
RecruitingHarran University802026-03-152026-10-19
Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training
Smell Training - Smell Loss, Chronic Rhinosinusitis (CRS)
Not applicableRecruitingThe Cleveland Clinic522025-12-092026-07-02
The German National CRS Registry (GenreCRS): Clinical Evaluation of the New European Academy for Allergy and Clinical Immunology (EAACI) Criteria for CRSwNP Disease Control, Remission and Cure in a Real-World Evidence Study Approach
Chronic Rhinosinusitis (CRS), Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Not yet recruitingÄrzteverband Deutscher Allergologen e.V.5002025-10-012025-06-04
Long-term Effect of Dupilumab in N-ERD
Observational follow-up of standard Dupilumab treatment - NSAID-Induced Asthma, NSAIDs Hypersensitivity
CompletedMedical University of Vienna152025-09-012026-10-07
Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps
Nasopharyngeal Lymphoid Tissue Ablation, Full-House Endoscopic Sinus Surgery - Nasal Polyps
Not applicableRecruitingTongji Hospital322025-07-012025-11-24
Complete Remission After Treatment With Biologics for Nasal Polyps
DUPIXENT®, NUCALA®, Dupi discontinuation - Nasal Polyps
Phase 4RecruitingCopenhagen University Hospital, Rigshospitalet662025-04-032025-12-05
Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry
Antiasthmatic - Chronic Asthma
RecruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz12002025-02-012026-03-30
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
611, Placebo - Sinusitis, Nasal Polyps
Phase 3Active not recruitingSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2432024-11-222025-12-03
Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
Dupilumab - Allergic Fungal Rhinosinusitis (AFRS), Chronic Rhinosinusitis (CRS)
Phase 3WithdrawnNational Institute on Deafness and Other Communication Disorders (NIDCD)2024-07-172024-07-25

Showing 20 of 157. Sign in to see all of them.

Narrower conditions

Sinusitis (23)  ·  Asthma (20)  ·  Disease (11)  ·  Rhinosinusitis (7)  ·  Nose Diseases (5)  ·  Rhinitis, Allergic (5)  ·  Asthma, Aspirin-Induced (4)  ·  Paranasal Sinus Diseases (4)  ·  Rhinitis (4)  ·  Respiratory Tract Diseases (3)  ·  Allergic Fungal Sinusitis (2)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Chronic Disease (2)  ·  Eosinophilia (2)

Broader conditions

Pathological Conditions, Anatomical (157)  ·  Pathological Conditions, Signs and Symptoms (157)  ·  Otorhinolaryngologic Diseases (155)  ·  Polyps (155)  ·  Respiratory Tract Diseases (154)  ·  Nose Diseases (152)  ·  Infections (34)  ·  Respiratory Tract Infections (33)  ·  Immune System Diseases (31)  ·  Hypersensitivity (29)  ·  Hypersensitivity, Immediate (29)  ·  Paranasal Sinus Diseases (28)  ·  Respiratory Hypersensitivity (27)  ·  Bronchial Diseases (23)  ·  Lung Diseases (23)

Interventions

Mometasone Furoate (14)  ·  dupilumab (10)  ·  mepolizumab (10)  ·  Omalizumab (8)  ·  Budesonide (6)  ·  Fluticasone (5)  ·  benralizumab (5)  ·  Prednisone (4)  ·  Blood Specimen Collection (3)  ·  Prednisolone (3)  ·  Standard of Care (3)  ·  Adrenal Cortex Hormones (2)  ·  Ambulatory Care Facilities (2)  ·  Biological Products (2)  ·  Doxycycline (2)

Sponsors

GlaxoSmithKline (9)  ·  Beijing Tongren Hospital (5)  ·  Brigham and Women's Hospital (5)  ·  AstraZeneca (4)  ·  Ain Shams University (3)  ·  Assiut University (3)  ·  Hoffmann-La Roche (3)  ·  Intersect ENT (3)  ·  Johns Hopkins University (3)  ·  Northwestern University (3)  ·  Organon and Co (3)  ·  University Hospital Ostrava (3)  ·  University Hospital, Ghent (3)  ·  University Hospital, Lille (3)  ·  Benjamin Bleier (2)

Countries

United States (60)  ·  China (18)  ·  Canada (17)  ·  France (17)  ·  Belgium (13)  ·  Spain (13)  ·  Germany (11)  ·  Poland (10)  ·  Czechia (9)  ·  Egypt (8)  ·  Italy (8)  ·  United Kingdom (8)  ·  Japan (7)  ·  Hungary (6)  ·  Netherlands (6)

Top investigators

Tanya M Laidlaw, MD (3)  ·  Benjamin S Bleier, MD (2)  ·  Claus Bachert, MD, PhD (2)  ·  Geoffrey Mortuaire, MD (2)  ·  Joseph K Han, MD (2)  ·  Lorena Soto-Retes, physician (2)  ·  Louis-Philippe Boulet, MD (2)  ·  Luo Zhang, MD (2)  ·  Ahmed Gamal Sholkamy, Doctor (1)  ·  Alan H. Shikani, MD (1)  ·  Aly Ragaie (1)  ·  Andrew Murr, MD (1)

Results publications

PMID 33710614, PMID 33548517, PMID 37951571, PMID 38197558, PMID 15817806, PMID 22469599, PMID 34110505, PMID 34382434, PMID 34437720, PMID 37214171, PMID 40037388, PMID 41461999, PMID 10480701, PMID 10719291, PMID 11240947, PMID 12049564, PMID 12091997, PMID 12789212, PMID 12903683, PMID 14616096, PMID 15117622, PMID 15379582, PMID 15647046, PMID 16218509, PMID 17075402, PMID 18331513, PMID 19289710, PMID 19713445, PMID 20638762, PMID 20738346, PMID 21271600, PMID 21357906, PMID 21676042, PMID 21714471, PMID 21739093, PMID 23193904, PMID 23255493, PMID 23331528, PMID 23818462, PMID 24337046, PMID 24589344, PMID 24817242, PMID 25137523, PMID 26046448, PMID 26452438, PMID 26575524, PMID 26679480, PMID 26836729, PMID 26992115, PMID 27924776

NIH funding

2017 (4), 2015 (2), 2023 (2), 2008 (1), 2016 (1), 2018 (1), 2019 (1), R37HL068546 (1), U19AI095219 (1)